Key result
Planned RCT tests if critical care outreach is noninferior to medical emergency teams for 30-day mortality.
Why the study?
The two most prevalent rapid response team constellations in the efferent limb, MET and CCOT, have not been previously compared in a clinical trial.
Does a nurse-led critical care outreach team (CCOT) compared to a doctor-led medical emergency team (MET) reduce 30-day mortality and serious adverse events in deteriorating hospitalized patients?
RCT (n=2,000)
Randomised at the time of the call
No
Does a nurse-led critical care outreach team (CCOT) compared to a doctor-led medical emergency team (MET) reduce 30-day mortality and serious adverse events in deteriorating hospitalized patients?
This study protocol outlines a randomized trial to compare the effectiveness of nurse-led versus doctor-led rapid response teams on mortality and adverse events in deteriorating patients.
Answers are grounded in this paper and cite their sources.
First RCT comparing MET vs CCOT compositions; will clarify optimal rapid response team staffing if noninferiority is shown.
BACKGROUND: Many patients experiencing deterioration have documented deviation of vital signs prior to the deterioration event. Increasing focus on these patients led to the rapid response systems and their configuration with afferent and efferent limbs. The two most prevalent team constellations in the efferent limb are the medical emergency team (MET), usually led by a doctor, and the critical care outreach team (CCOT), usually led by a nurse. The two constellations have not previously been examined in a comparative clinical trial. METHODS: This is a single centre non-inferiority randomised controlled trial of MET vs CCOT. All patients will be randomised at the time of the call. The intervention group will be the critical care outreach team. The primary outcome is mortality at 30 days and the occurrence of serious adverse events. All patients will be followed for 90 days. We aim to detect or reject a change of 7% in mortality whilst accepting a type I error of 5 and type II error of 20, using a sample size of maximum of 2000 individual patients. DISCUSSION: There is evidence supporting a benefit for the patient when using rapid response systems; however, earlier randomised studies are marked by cross-contamination and selection bias. Previous studies have primarily examined the effect of RRS on hospital cardiac arrests (IHCA) and mortality. Our study will be examining the effect on intensive care unit admissions as well as the ICHA and mortality. CONCLUSION: This study may highlight potential benefits of specific configurations of rapid response systems and their impact on safety outcomes.
No takes yet. Share an insight, caveat, or question.
Føns‐Sønderskov et al. (2021) conducted an RCT in Clinical deterioration (n=2,000). Critical care outreach team (CCOT) vs. Medical emergency team (MET) was evaluated on Mortality at 30 days and the occurrence of serious adverse events. A planned randomized controlled trial will evaluate whether a critical care outreach team is noninferior to a medical emergency team for 30-day mortality and serious adverse events in 2000 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: